Clinical trial

A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT02754882

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-07-05

PhasePHASE3

Study timeline

Study start (actual)2016-07-05Date precision: day

Registry last updated2024-12-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Non-small Cell Lung Cancerunresolved

Interventions

BevacizumabDRUG · verified · RxNorm: bevacizumab

SB8DRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

Samsung Bioepis Co., Ltd.lead sponsor

Mapped research locations

Saint PetersburgRussia5 BudapestHungary3 SeoulSouth Korea2 MadridSpain2 MoscowRussia2 BucharestRomania2 Kaohsiung CityTaiwan2 BelgradeSerbia2 BusanSouth Korea2 IașiRomania2 SevilleSpain1 TaichungTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02754882 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.